Theravance Biopharma Inc (TBPH)

Jun 15, 2026

13,314 restricted shares listed for sale by TBPH (NASDAQ: TBPH) — Rule 144 notice - Stock Titan

Jun 15, 2026

Jun 13, 2026

Theravance Biopharma, Inc. 8-K Filing Details: Annual Meeting Results, Auditor Appointment, and Company Information (June 2026) - Minichart

Jun 13, 2026

Jun 12, 2026

Theravance Biopharma Shareholders Back Directors and Governance Plans - TipRanks

Jun 12, 2026

Jun 12, 2026

Theravance Biopharma (NASDAQ: TBPH) investors approve directors, auditor and pay plan - Stock Titan

Jun 12, 2026

Jun 12, 2026

TBPH News | THERAVANCE BIOPHARMA INC (NASDAQ:TBPH) - ChartMill

Jun 12, 2026

Jun 12, 2026

Theravance stock declines around 17% in three months: Here's why - MSN

Jun 12, 2026

Jun 12, 2026

Jones Trading Initiates Coverage of Theravance Biopharma (TBPH) with Buy Recommendation - MSN

Jun 12, 2026

Jun 08, 2026

TBPH Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost DisciplineRevenue Surprise History - newsline.com

Jun 08, 2026

Jun 06, 2026

Avoiding Lag: Real-Time Signals in (TBPH) Movement - Stock Traders Daily

Jun 06, 2026

May 29, 2026

Theravance Biopharma (TBPH) Edges Lower Amid Mixed Technical Signals – Key Levels to MonitorEarnings Beat Stocks - newsline.com

May 29, 2026

May 28, 2026

JonesTrading Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Raises Target Price to $19 - Moomoo

May 28, 2026

May 27, 2026

Theravance Biopharma: Solid 1Q26 Execution, Cost Cuts, and YUPELRI Momentum Drive Buy Rating and Price Target Increase to $19 - TipRanks

May 27, 2026

May 26, 2026

Discipline and Rules-Based Execution in TBPH Response - Stock Traders Daily

May 26, 2026

May 22, 2026

Theravance Biopharma (TBPH) CEO has shares withheld to cover RSU taxes - Stock Titan

May 22, 2026

May 22, 2026

Theravance Biopharma (NASDAQ: TBPH) CFO has 8,670 shares withheld for RSU taxes - Stock Titan

May 22, 2026

May 22, 2026

Theravance Biopharma (TBPH) SVP has shares withheld for RSU taxes - Stock Titan

May 22, 2026

May 22, 2026

Theravance Biopharma (TBPH) SVP has 8,829 shares withheld for RSU tax - Stock Titan

May 22, 2026

May 22, 2026

Theravance Biopharma (TBPH) SVP uses 5,678 shares to cover tax bill - Stock Titan

May 22, 2026

May 18, 2026

Theravance Biopharma (TBPH) Q4 earnings and revenues lag estimates - MSN

May 18, 2026

May 16, 2026

Behavioral Patterns of TBPH and Institutional Flows - Stock Traders Daily

May 16, 2026

May 14, 2026

TradingKey - TradingKey

May 14, 2026

May 13, 2026

Are Options Traders Betting on a Big Move in Theravance Biopharma Stock? - TradingView

May 13, 2026

May 11, 2026

BTIG Maintains Theravance Biopharma (TBPH) Buy Recommendation - MSN

May 11, 2026

May 09, 2026

Here's why Theravance Biopharma (TBPH) is a strong momentum stock - MSN

May 09, 2026

May 08, 2026

TBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline Hurdle - sharewise.com

May 08, 2026

May 08, 2026

BTIG Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Maintains Target Price $21 - Moomoo

May 08, 2026

May 08, 2026

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Strong Revenue Growth and Strategic Collaborations Point to Promising Future - DirectorsTalk Interviews

May 08, 2026

May 07, 2026

Theravance Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026

May 07, 2026

Earnings Flash (TBPH) Theravance Biopharma, Inc. Reports Q1 Revenue $17.7M, vs. FactSet Est of $17.8M - marketscreener.com

May 07, 2026

May 07, 2026

Theravance Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2026

May 07, 2026

Theravance Biopharma (NASDAQ: TBPH) slashes R&D after ampreloxetine trial miss - Stock Titan

May 07, 2026

May 07, 2026

Theravance Biopharma reports Q1 2026 revenue $17.7M, narrows net loss to $4.9M - TradingView

May 07, 2026

May 07, 2026

Ireland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth - TradingView

May 07, 2026

May 07, 2026

Theravance Bio: Q1 Earnings Snapshot - KTVB

May 07, 2026

May 07, 2026

Theravance (NASDAQ: TBPH) targets $60–70M cash flow after major restructuring - Stock Titan

May 07, 2026

May 07, 2026

Theravance Biopharma: Confident Will Achieve $100 Million Milestone Payment Associated With 2026 Trelegy Net Sales >TBPH - Moomoo

May 07, 2026

May 07, 2026

Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update - ChartMill

May 07, 2026

May 06, 2026

MSN Money - MSN

May 06, 2026

May 04, 2026

(TBPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

May 04, 2026

May 04, 2026

Theravance's Q4 earnings and revenues miss estimates - MSN

May 04, 2026

May 02, 2026

Theravance Biopharma (NASDAQ:TBPH) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat

May 02, 2026